MBCOF (Marvel Biosciences) Total Equity: $-1.99 Mil (As of Apr. 2026)


MBCOF Marvel Biosciences Corp MBCOF
33 GF Score
Price $0.12
! 1 Warning Sign
View Full Analysis

What is Marvel Biosciences Total Equity?

Marvel Biosciences MBCOF +4.74% 33 Total Equity is $-1.99 Mil as of Apr. 2026. GuruFocus rates MBCOF with a GF Score™ of 33/100. The stock has 1 warning sign investors should review.

Marvel Biosciences's total equity for the quarter that ended in Apr. 2026 was $-1.99 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Marvel Biosciences Total Equity Historical Data

* Premium members only.

The historical data trend for Marvel Biosciences's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Marvel Biosciences Total Equity Chart

Marvel Biosciences Annual Data
Trend Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Total Equity
Get a 7-Day Free Trial 1.88 0.15 -1.30 -2.06 -2.93

Marvel Biosciences Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.09 -2.93 -2.61 -2.80 -1.99
MBCOF
33GF Score
Marvel Biosciences Corp MBCOF
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Marvel Biosciences Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Marvel Biosciences's Total Equity for the fiscal year that ended in Jul. 2025 is calculated as

Total Equity=Total Assets(Q: Jul. 2025 )-Total Liabilities(Q: Jul. 2025 )
=0.239-3.165
=-2.93

Marvel Biosciences's Total Equity for the quarter that ended in Apr. 2026 is calculated as

Total Equity=Total Assets(Q: Apr. 2026 )-Total Liabilities(Q: Apr. 2026 )
=0.343-2.331
=-1.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $-1.99 Mil mean?
Marvel Biosciences (MBCOF) has a Total Equity of $-1.99 Mil as of Apr. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Marvel Biosciences and its competitors.
Is Marvel Biosciences' Total Equity too high?
Marvel Biosciences' current Total Equity is $-1.99 Mil. Overall, Marvel Biosciences has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Marvel Biosciences' Total Equity compare to VRTX and REGN?
Marvel Biosciences' Total Equity of $-1.99 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Marvel Biosciences and its competitors. Marvel Biosciences's current Total Equity is $-1.99 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Marvel Biosciences stock overvalued right now?
Marvel Biosciences (MBCOF) has a current Total Equity of $-1.99 Mil. The current Total Equity is $-1.99 Mil. Marvel Biosciences' overall GF Score™ is 33/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Marvel Biosciences (MBCOF), the current Total Equity is $-1.99 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Marvel Biosciences Business Description

Other Exchanges MRVL:Canada
Address 505 - 8th Avenue SW, Suite 420, Calgary, AB, CAN, T2P1G2
Marvel Biosciences Corp is a biotechnology company incorporated in Canada. The Company is currently a pre-clinical stage pharmaceutical development company that utilizes a drug redevelopment approach to identify and evaluate potential therapeutic compounds. Its activities mainly involve scientific research and pre-clinical studies aimed at determining viable active compounds for further drug development.
33GF Score

Get the complete analysis for MBCOF

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.12
Price